Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meixiao Long

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Cell Reports|February 23, 2022
Systematic illumination of druggable genes in cancer genomesJunjie Jiang, Jiao Yuan, Zhongyi Hu, et al.
Nature Cancer|February 5, 2022
The Cancer Surfaceome Atlas integrates genomic, functional and drug response data to identify actionable targetsZhongyi Hu, Jiao Yuan, Meixiao Long, et al.
Leukemia & Lymphoma|March 2, 2019
Modulation of immune checkpoint molecule expression in mantle cell lymphomaBonnie K Harrington, Esther Wheeler, Kasey Hornbuckle, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
Repression of PRMT activities sensitize homologous recombination-proficient ovarian and breast cancer cells to PARP inhibitor treatmentYouyou Zhang, Mu Xu, Jiao Yuan, et al.
Plos Genetics|February 15, 2020
Integrative comparison of the genomic and transcriptomic landscape between prostate cancer patients of predominantly African or European genetic ancestryJiao Yuan, Kevin H Kensler, Zhongyi Hu, et al.
Cell Reports|July 16, 2020
Systematic Characterization of Recurrent Genomic Alterations in Cyclin-Dependent Kinases Reveals Potential Therapeutic Strategies for Cancer TreatmentWeiwei Shan, Jiao Yuan, Zhongyi Hu, et al.
Cancer Cell|March 16, 2005
Androgen ablation mitigates tolerance to a prostate/prostate cancer-restricted antigenCharles G Drake, Amy D H Doody, Marianne A Mihalyo, et al.
Nature Immunology|October 20, 2022
SUSD2 suppresses CD8<sup>+</sup> T cell antitumor immunity by targeting IL-2 receptor signalingBao Zhao, Weipeng Gong, Anjun Ma, et al.
Blood Advances|January 4, 2018
BRAF<sup>V600E</sup> accelerates disease progression and enhances immune suppression in a mouse model of B-cell leukemiaYo-Ting Tsai, Aparna Lakshmanan, Amy Lehman, et al.
Nature Communications|February 15, 2019
Genomic characterization of genes encoding histone acetylation modulator proteins identifies therapeutic targets for cancer treatmentZhongyi Hu, Junzhi Zhou, Junjie Jiang, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Cell Reports|February 23, 2022
Systematic illumination of druggable genes in cancer genomesJunjie Jiang, Jiao Yuan, Zhongyi Hu, et al.
Nature Cancer|February 5, 2022
The Cancer Surfaceome Atlas integrates genomic, functional and drug response data to identify actionable targetsZhongyi Hu, Jiao Yuan, Meixiao Long, et al.
Leukemia & Lymphoma|March 2, 2019
Modulation of immune checkpoint molecule expression in mantle cell lymphomaBonnie K Harrington, Esther Wheeler, Kasey Hornbuckle, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
Repression of PRMT activities sensitize homologous recombination-proficient ovarian and breast cancer cells to PARP inhibitor treatmentYouyou Zhang, Mu Xu, Jiao Yuan, et al.
Plos Genetics|February 15, 2020
Integrative comparison of the genomic and transcriptomic landscape between prostate cancer patients of predominantly African or European genetic ancestryJiao Yuan, Kevin H Kensler, Zhongyi Hu, et al.
Cell Reports|July 16, 2020
Systematic Characterization of Recurrent Genomic Alterations in Cyclin-Dependent Kinases Reveals Potential Therapeutic Strategies for Cancer TreatmentWeiwei Shan, Jiao Yuan, Zhongyi Hu, et al.
Cancer Cell|March 16, 2005
Androgen ablation mitigates tolerance to a prostate/prostate cancer-restricted antigenCharles G Drake, Amy D H Doody, Marianne A Mihalyo, et al.
Nature Immunology|October 20, 2022
SUSD2 suppresses CD8<sup>+</sup> T cell antitumor immunity by targeting IL-2 receptor signalingBao Zhao, Weipeng Gong, Anjun Ma, et al.
Blood Advances|January 4, 2018
BRAF<sup>V600E</sup> accelerates disease progression and enhances immune suppression in a mouse model of B-cell leukemiaYo-Ting Tsai, Aparna Lakshmanan, Amy Lehman, et al.
Nature Communications|February 15, 2019
Genomic characterization of genes encoding histone acetylation modulator proteins identifies therapeutic targets for cancer treatmentZhongyi Hu, Junzhi Zhou, Junjie Jiang, et al.
Pageof 4